NEW YORK, Oct. 1 /PRNewswire-FirstCall/ -- Forest Laboratories, Inc.
(NYSE: FRX), an international manufacturer and marketer of pharmaceutical
products, will release its Fiscal 2009 Second Quarter financial results
before the U.S. stock market opens on Tuesday, October 21, 2008. Later that
day, at 10:00 AM EDT, Forest will host a conference call where Dr. Lawrence
Olanoff, President and Chief Operating Officer and Frank Perier, Senior
Vice President-Finance and Chief Financial Officer, will discuss the
financial results and relevant company and industry topics. The conference
call will be webcast live beginning at 10:00 AM EDT on the Company's
website http://www.frx.com and also on the website http://www.streetevents.com. Please
log on to either website at least fifteen minutes prior to the conference
call as it may be necessary to download software to access the call. A
replay of the conference call will be available until October 31, 2008 at
both websites and also by dialing 1-866-859-6142 (US investors) or
+1-706-679-7668 (international investors), ID 67369178
(Logo: http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO )
About Forest Laboratories
Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company
with a long track record of building partnerships and developing and
marketing products that make a positive difference in people's lives. In
addition to its well-established franchises in therapeutic areas of the
central nervous and cardiovascular systems, Forest's current pipeline
includes product candidates in all stages of development and across a wide
range of therapeutic areas. The company is headquartered in New York, NY.
To learn more about Forest Laboratories, visit http://www.FRX.com.
Except for the historical information contained herein, this release
contains forward-looking statements within the meaning of the Private
Securities Litigation Reform Act of 1995. These statements involve a number
of risks and uncertainties, including the difficulty of predicting FDA
approvals, the acceptance and demand for new pharmaceutical products, the
impact of competitive products and pricing, the timely development and
launch of new products, and the risk factors listed from time to time in
the Forest Laboratories' Annual Report on Form 10-K, Quarterly Reports on
Form 10-Q, and any subsequent SEC filings.
SOURCE Forest Laboratories, Inc.
 back to top
Related links:
http://www.frx.com
Photo Notes:http://www.newscom.com/cgi-bin/prnh/20001011/FORESTLOGO
AP Archive: http://photoarchive.ap.org
PRN Photo Desk, photodesk@prnewswire.com
CONTACT:
Frank J. Murdolo, Vice President-Investor
Relations, Forest Laboratories, Inc., +1-212-224-6714,
frank.murdolo@frx.com
|
